Fulvio Michelis
Research Subjects
Research Interests
Fulvio Michelis has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ammar Halabi
Global Digital Health, Ares Trading SA, Eysins, Switzerland
1 shared publication - Ekaterina Koledova
Global Medical Affairs, Cardiometabolic and Endocrinology, Merck Healthcare KGaA, Darmstadt, Germany
1 shared publication - Guido Giunti
University of Oulu
1 shared publication - Jamie Harvey
The MAGIC Foundation, Warrenville, IL, USA
1 shared publication - Paul Dimitri
NIHR HealthTech Research Centre in Paediatrics and Child Health, Sheffield Children’s Hospital NHS Foundation Trust, Sheffield, UK
1 shared publication
Latest Publications
- Open Access
- 22 November 2024
- Published by IOS Press
- Vol. 321, 74-78
The Pediatric Growth Hormone Deficiency Patient Journey: Identifying Opportunities for Digital Health Interventions
Pediatric growth hormone deficiency (PGHD) is a chronic condition where the pituitary gland fails to produce sufficient growth hormone, leading to delayed growth and developmental challenges. Patient journey maps can provide insight into pain points and potential opportunities for new or improved interventions to enhance care. However, a patient journey map does not yet exist for PGHD. Secondary data analysis was performed on interviews and focus groups from five cohorts in Sweden, the United Kingdom, Luxembourg, France, and The Netherlands. Participants included 62 patients and caregivers who used a prototype digital health solution, which was used to guide discussions. Grounded theory was used to analyze the data, resulting in a patient journey map comprising six stages: awareness, diagnosis, treatment planning, treatment initiation, treatment maintenance and transition. This provides the first detailed PGHD patient journey map, revealing emotional sensitivities and challenges at each stage, and suggesting areas for targeted interventions to improve adherence and long-term outcomes.
- 22 November 2024
- Published by IOS Press
- Vol. 321, 74-78
Open AccessThe Pediatric Growth Hormone Deficiency Patient Journey: Identifying Opportunities for Digital Health Interventions
Pediatric growth hormone deficiency (PGHD) is a chronic condition where the pituitary gland fails to produce sufficient growth hormone, leading to delayed growth and developmental challenges. Patient journey maps can provide insight into pain points and potential opportunities for new or improved interventions to enhance care. However, a patient journey map does not yet exist for PGHD. Secondary data analysis was performed on interviews and focus groups from five cohorts in Sweden, the United Kingdom, Luxembourg, France, and The Netherlands. Participants included 62 patients and caregivers who used a prototype digital health solution, which was used to guide discussions. Grounded theory was used to analyze the data, resulting in a patient journey map comprising six stages: awareness, diagnosis, treatment planning, treatment initiation, treatment maintenance and transition. This provides the first detailed PGHD patient journey map, revealing emotional sensitivities and challenges at each stage, and suggesting areas for targeted interventions to improve adherence and long-term outcomes.